150 years dedicated to ophthalmology

The Chibret family A passion for trachoma

Paul CHIBRET, a military doctor based in Algeria,  developed an interest in trachoma, an eye disease that would fascinate him all his life

The Chibret family S.F.O.

Paul Chibret founds the French Society of Ophthalmology and develops innovative ophthalmic treatment along with his nephew Henry. 

The Chibret family Laboratoires Chibret

Henry Chibret sets up Chibret Laboratoires in Clermont-Ferrand, France.

Sur the picture : the second pharmacy of Henry Chibret in 1920
 

The Chibret family The leading ophthalmic company

Under Jean Chibret's management, Chibret Laboratoires becomes the leading ophthalmic company in Europe, Africa and the Middle East.

Sur on the picture : the Chibret laboratories in the sixties 
 

The Chibret family MSD-Chibret

MSD merges with Chibret to create Laboratoires MSD-Chibret. 

On the picture : packaging line at the boulevard Clémentel site in Clermont-Ferrand in the early sixities

The start-up spirit Biophysic Medical

Jean's two sons, Jacques and Henri, take over in the late 70's: Jacques Chibret founds Biophysic Médical, specialized in laser and ultra-sound equipments for the treatment and diagnosis of eyes diseases. Biophysic Médical becomes a world leader.
 

The start-up spirit Transphyto

Jean's two sons, Jacques and Henri, take over in the late 70's:  Henri Chibret creates Transphyto, an independent ophthalmic Research and Development laboratory, its innovations being entrusted to licensees for active marketing. 

The start-up spirit Laboratoires Théa

With the creation of the Théa Laboratories, Henri Chibret decides to directly commercialize the products developed by Transphyto's research.

Laboratoires Théa The first ABAK® bottle

The first ABAK^® bottle with the launch of an ocular anti-allergic.
 

The early days of the international expansion The first subsidiary

Creation of the first subsidiary: Laboratorios Théa in Spain. 

The early days of the international expansion Théa Pharma Belgium

Creation of Théa Pharma in Belgium.

An eventful year Merger of Transphyto/Théa

Merger of Transphyto and Laboratoires Théa /  Creation of Théa Pharma in Switzerland and Laboratoires Théa in Portugal.

A year of acquisitions Farmila Blepharma

Acquisition of an Italian Ophthalmic Laboratory, Farmila. /  Acquisition of several Belpharma products which strengthens Théa's position in Belgium and gives access to the Dutch market.

Extension of the product range Worldwide acquisition

Worldwide acquisition of a range of MSD ophthalmic products. 

A symbolic threshold A historic turnover

Consolidated revenues reach 100 million euros

the expansion continues Europe and Africa

Creation of an exclusive sales network in Africa and North Africa /  Creation of Théa Pharma in Germany.
Creation of Pharm-Supply Théa AG in Poland. 

The acquisitions continue Europhta

Acquisition of Europhta Laboratories in Monaco. 

New location Joint-venture Spectrum Théa

Creation of a joint-venture Spectrum Théa in Great Britain and Ireland /  Théa becomes a shareholder in Sisène, a start-up arising from INSERM.

New range and location The international expansion continues

Worldwide acquisition of a range of ophthalmic products from Novartis / Launch of our activity in Russia.

Product range Acquisition of a mydriatic insert

Acquisition of the ophthalmic insert from Carl Zeiss Meditec.

New products and affiliates Beyond the borders

Acquisition of a wide range of ophthalmic products from Novartis in 30 European countries, as well as in Turkey, Canada and Mexico / Creation of affiliates in Austria and Turkey and opening of the Nordic subsidiary in Sweden, covering Scandinavia and Finland. 

Expansion and Innovation Sharing knowledge

• Launch of the Théa Foundation / Launch of the Tube with the Steri-Free^® technology for cosmetic products. 

New location Théa Mexico

Creation of Théa Mexico

New locations Théa in Morocco and Ukraine

Creation of Théa in Morocco and Ukraine